| Financial Year |
March 31 2023 |
| Monetary Funds |
271,213,808.49 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
214,917,665.75 |
| Advances to Suppliers |
42,041,994.52 |
| Other Receivables |
1,615,174.66 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
95,625,046.03 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,515,981.74 |
| Total Current Assets |
674,215,339.89 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
357,852,154.63 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
71,311,477.68 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
14,771,343.12 |
| Other Non-Current Assets |
2,330,089.69 |
| Sub-Total of Non-Current Assets |
447,365,065.12 |
| Total Assets |
1,121,580,405.01 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
18,869,646.27 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
37,181,523.94 |
| Taxes Payable |
15,478,945.94 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
40,045,980.68 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
179,965.86 |
| Sub-Total of Current Liabilities |
116,884,111.95 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
29,598,566.33 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
37,017,210.14 |
| Total Liabilities |
153,901,322.09 |
| Paid-In Capital(Or Share Stock) |
863,977,948.00 |
| Capital Surplus |
697,688,282.20 |
| Surplus Reserve |
212,588,236.99 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,350,001,908.27 |
| Minority Stockholder's Interest |
543,426,524.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
424,252,558.92 |
| Owner's Equity（Stockholder's Equity） |
967,679,082.92 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,121,580,405.01 |
